ROVI achieved stable total revenue of 381.0 million euros in the first post-pandemic half year
4 min
26 Jul, 2023
ROVI reached 201.9 million euros of revenue in the first post-pandemic quarter
3 min
10 May, 2023
The objective of the new three-monthly formulation is to reach bioequivalence in the plasma levels of letrozole in...
6 min
25 Apr, 2023
The objective is to help improve society’s mental health and take advantage of the opportunities the new technologies...
3 min
12 Apr, 2023
The group is collaborating with ReTree to recover an area of the Sierra del Rincón through reforestation with native...
3 min
27 Mar, 2023
ROVI joins BioSim to strengthen initiatives that promote greater access to and knowledge about biosimilar medicines.
3 min
21 Mar, 2023
ROVI reports operating revenue growth of 26% and EBITDA growth of 37%
3 min
21 Feb, 2023
ROVI has now filed the final responses to the Complete Response Letter received from the United States Food and Drug...
2 min
16 Feb, 2023
The Minister, Alexandru Rafila, was accompanied by the Director of Cabinet of the Romanian Ministry of Health and the...
2 min
06 Feb, 2023